PubMed=2004854; DOI=10.1002/ijc.2910470518
Hiroshi Kuroda, Tohru Sugimoto, Kazumitsu Ueda, Shigeki Tsuchida, Yoshihiro Horii, Johji Inazawa, Kiyomi Sato, Tadashi Sawada;
Different drug sensitivity in two neuroblastoma cell lines established from the same patient before and after chemotherapy.
Int. J. Cancer 47:732-737(1991)

DOI=10.1007/0-306-46872-7_2
Carol Jeanne Thiele;
Neuroblastoma.
(In book chapter) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters, John R.W. & Palsson, Bernhard Orn (eds.); pp.21-53; Kluwer Academic Publishers; New York; USA (1999)

PubMed=12702577
Fumiko Saito-Ohara, Issei Imoto, Jun Inoue, Hajime Hosoi, Akira Nakagawara, Tohru Sugimoto, Johji Inazawa;
PPM1D is a potential target for 17q gain in neuroblastoma.
Cancer Res. 63:1876-1883(2003)

PubMed=23268333; DOI=10.1016/j.canlet.2012.12.011
Tohru Sugimoto, Takahiro Gotoh, Shigeki Yagyu, Hiroshi Kuroda, Tomoko Iehara, Hajime Hosoi, Sigeru Ohta, Miki Ohira, Akira Nakagawara;
A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines.
Cancer Lett. 331:115-121(2013)

CLPUB00582
Tohru Sugimoto, Hiroshi Kuroda, Shigeki Yagyu, Takahiro Gotoh, Shinya Osone, Shinichi Tamura, Tomoko Iehara, Hajime Hosoi;
Cellular and molecular characteristics of established neuroblastoma cell lines.
J. Cancer Res. Therap. Oncol. 7:201.1-201.15(2019)